Floyd, J S <br/><br/>
Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.  [electronic resource] 

 -  The pharmacogenomics journal  01 2018 
 - 127-135 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2016.90  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiovascular Diseases--chemically induced<br/>Cytochrome P-450 CYP2C9--genetics<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Drug-Related Side Effects and Adverse Reactions--genetics<br/>Electrocardiography--drug effects<br/>Ethnicity--genetics<br/>Female<br/>Genetic Variation--drug effects<br/>Genome-Wide Association Study--methods<br/>Humans<br/>Male<br/>Middle Aged<br/>Pharmacogenetics--methods<br/>Pharmacogenomic Testing--methods<br/>Sulfonylurea Compounds--adverse effects